| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Albéa S.A. (TBA) | BofA Merrill Lynch/ J.P. Morgan/ Goldman Sachs | $150.00 | n.a. | |||
| Auris Medical Holding AG (EARS) | Jefferies/ Leerink Partners | $86.25 | n.a. | |||
| Avalanche Biotechnologies (AAVL) | Jefferies/ Cowen and Company/ Piper Jaffray | $86.25 | n.a. | |||
| Diplomat Pharmacy (TBA) | Credit Suisse/ Morgan Stanley/ J.P. Morgan/ Wells Fargo Securities/ William Blair/ Leerink Partners | $100.00 | n.a. | |||
| DT Asia Investments Ltd (CADTU) (u) | EarlyBirdCapital | 6.00 | $10.00 | $10.00 | $60.00 | n.a. |
| Expro Oilfield Services PLC (TBA) | TBA | $100.00 | n.a. | |||
| Hoegh LNG Partners LP (TBA) | Citigroup/ BofA Merrill Lynch/ Morgan Stanley | $100.00 | n.a. | |||
| iDreamSky Technology (DSKY) | Credit Suisse/ J.P. Morgan | $115.00 | n.a. | |||
| Loxo Oncology (LOXO) | Cowen and Company/ Stifel | $69.00 | n.a. | |||
| OM Asset Management Ltd (OMAM) | BofA Merrill Lynch/ Morgan Stanley/ Citigroup/ Credit Suisse | $100.00 | n.a. | |||
| T2 Biosystems (TTOO) | Goldman Sachs/ Morgan Stanley | $69.00 | n.a. | |||
| Viamet Pharmaceuticals (VIAM) | Piper Jaffray/ Stifel/ Wells Fargo Securities | $86.25 | n.a. | |||
| Viking Therapeutics (VKTX) | Oppenheimer/ Roth Capital Partners | $57.50 | n.a. | |||
| Yodlee (YDLE) | Goldman Sachs/ Credit Suisse/ BofA Merrill Lynch | $75.00 | n.a. | |||
| Zayo Group Holdings (TBA) | Morgan Stanley/ Barclays/ Goldman Sachs | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Ambrx (AMBX) | Stifel/ Wells Fargo Securities | 5.40 | $12.00 | $14.00 | $86.25 | 2-Stars |
| Gates Global (TBA) | BofA Merrill Lynch/ Citigroup/ Goldman Sachs/ Barclays/ Credit Suisse/ J.P. Morgan/ RBC Capital Markets | $100.00 | n.a. | |||
| Transport America (TRAM) | Baird/ Stifel | $75.00 | n.a. | |||
| Taggares Agriculture (TAG) | Janney Montgomery Scott/ ROTH Capital Partners | 7.00 | $6.00 | $7.00 | $45.50 | 1-Star |
| New Terms | ||||||
| ContraFect (CFRXU) (u) | Maxim Group LLC | 3.64 | $5.00 | $6.00 | $20.00 | n.a. |
| GlobeImmune (GBIM) | Aegis Capital Corp. | 1.00 | $15.00 | $15.00 | $15.00 | 1-Star |
| Microlin Bio (MCLB) | Brean Capital/ Sunrise Securities | 5.50 | $4.50 | $5.50 | $27.50 | 1-Star |
| Minerva Neurosciences (NERV) | Jefferies | 5.45 | $6.00 | $6.00 | $32.73 | 1-Star |
| TerraForm Power (TERP) | Goldman Sachs/Barclays/ Citigroup/J.P. Morgan/ Macquarie Capital | $550.00 | n.a. | |||
| Westlake Chemical Partners LP (WLKP) | Barclays/ UBS Investment Bank/ BofA Merrill Lynch/ Deutsche Bank Securities/ Morgan Stanley | $271.69 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of June 30, 2014 | Manager(s) | Offered | Raised | Price | 7/3/14 | Change |
| GlobeImmune (GBIM) | Aegis Capital Corp. | 1.50 | $15.00 | $10.00 | $11.85 | 18.50% |
| Minerva Neurosciences (NERV) | Jefferies | 5.45 | $32.73 | $6.00 | $6.13 | 2.17% |
| Investar Holding (ISTR) | Sandler O’Neill + Partners/ Sterne Agee | 2.88 | $40.25 | $14.00 | $14.05 | 0.36% |
